US Broker Ratings

CONMED Corporation (CNMD) Investor Outlook: Exploring a 12.38% Potential Upside with Analyst Insights

For investors looking to delve into the healthcare sector, particularly the medical devices industry, CONMED Corporation (NASDAQ: CNMD) presents an intriguing opportunity. With a market capitalization..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a 50% Potential Upside in the Biotech Sector

Scholar Rock Holding Corporation (NASDAQ: SRRK), a prominent player in the biotechnology industry, has captured investor attention with its innovative approach to treating serious diseases through..

National HealthCare Corporation (NHC): Investor Outlook with a Healthy Revenue Growth of 28.7%

National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 162% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing the attention of investors with its significant potential upside of 162.24%, as indicated by its average target price of..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 46% Upside Potential for Investors

Twist Bioscience Corporation (NASDAQ: TWST) has captured the attention of investors with its innovative approach to synthetic DNA-based products. Operating within the healthcare sector, specifically in..

SS Innovations International (SSII) Stock Analysis: A Deep Dive into 121.80% Revenue Growth in the Healthcare Sector

SS Innovations International Inc. (NASDAQ: SSII), a promising player in the healthcare sector, is capturing attention with its impressive 121.80% revenue growth. As a commercial-stage surgical..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 39% Upside Potential Amidst Biotech Challenges

For investors eyeing the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a fascinating opportunity with both risks and significant upside potential. Based in Waltham, Massachusetts,..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 35% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Mechanicsburg, Pennsylvania,..

QuidelOrtho Corporation (QDEL) Investor Outlook: Exploring a Potential 56% Upside

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, operates within the medical devices industry. Headquartered in San Diego, California, QuidelOrtho provides cutting-edge diagnostic..

NovoCure Limited (NVCR) Stock Analysis: Potential 132% Upside as Innovative Cancer Treatments Drive Growth

Investors eyeing the healthcare sector may find NovoCure Limited (NASDAQ: NVCR) a compelling prospect, especially given its potential upside of 132.37%. As a key player in..

Disc Medicine, Inc. (IRON) Stock Analysis: A Look at the 67.86% Potential Upside in Biotech Innovation

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, has been capturing investor attention with its robust pipeline of innovative treatments for serious hematologic diseases. As..

Alvotech (ALVO) Stock Analysis: Unveiling a 110% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO) stands as a notable player in the healthcare sector, specializing in the development and manufacturing of biosimilar medicines. Based in Luxembourg, this company..

Addus HomeCare Corporation (ADUS) Stock Analysis: 20.72% Upside Potential Fuels Investor Interest

Addus HomeCare Corporation (NASDAQ: ADUS) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Metsera, Inc. (MTSR) Stock Analysis: A Biotechnology Disruptor with a 75.92% Potential Upside

Metsera, Inc. (NASDAQ: MTSR), a burgeoning player in the biotechnology sector, is capturing significant attention with its promising pipeline of treatments for obesity and related conditions...

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating Growth Challenges with Promising CNS Treatments

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company headquartered in Rockville, Maryland, continues to capture investor attention as it navigates the complex landscape of central nervous..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 49% Potential Upside for Investors

UFP Technologies, Inc. (UFPT) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative solutions. Based in Newburyport, Massachusetts, the..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 41.93% Upside Potential in the Biotech Sector

MoonLake Immunotherapeutics (Nasdaq: MLTX) has captured the attention of investors with its promising pipeline in the competitive biotechnology sector. Based in Zug, Switzerland, this clinical-stage biotech..

LivaNova PLC (LIVN) Stock Analysis: Forecasting a 15% Upside Potential in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors seeking exposure to..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Exploring a 66% Potential Upside in Biotech

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with an impressive trajectory of developing and commercializing treatments for rare diseases. As an investor,..

Galapagos NV (GLPG) Stock Analysis: Navigating a -18.96% Potential Downside Amid Biotech Uncertainties

Galapagos NV (NASDAQ: GLPG), headquartered in Mechelen, Belgium, draws investor attention within the dynamic biotechnology sector, focusing on groundbreaking medicines in oncology and immunology. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds